Cardiosense announced today that it received FDA 510 (k) clearance for its CardioTag wearable sensor device.

Gender-affirming hormone therapies (GAHT) were associated with some cardiac repolarization alterations evident on ...

A routine, low-cost heart test may be on the verge of a transformative upgrade thanks to artificial intelligence. With ...